The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions - Takeaways - MDSpire

The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions

  • By

  • Xinuo Ma

  • Feng Wang

  • Dajin Liu

  • Ying Li

  • Ping Xia

  • Yunyun Xu

  • Han Xia

  • Yujuan Peng

  • Lixing Chen

  • June 8, 2026

  • 0 min

Share

  • 1

    The C-reactive protein-triglyceride-glucose index (CTI) is a novel biomarker that integrates inflammation and insulin resistance.

  • 2

    Elevated CTI levels are associated with a significantly higher risk of all-cause mortality in patients with chronic heart failure.

  • 3

    CTI serves as an independent prognostic marker for all-cause mortality across different ejection fraction subtypes in heart failure patients.

  • 4

    Subgroup analysis indicates that higher CTI levels correlate with increased mortality in patients with heart failure with reduced and mildly reduced ejection fraction.

  • 5

    The study emphasizes the importance of CTI as a potential tool for risk stratification in chronic heart failure management.

Original Source(s)

The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions

  • by Xinuo Ma, Feng Wang, Dajin Liu, Ying Li, Ping Xia, Yunyun Xu, Han Xia, Yujuan Peng, Lixing Chen

  • June 8, 2026

Related Content

Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

Comprehensive analysis of clinical features, electrocardiogram, and imaging in de Winter syndrome